Becton Dickinson loses its CFO to Round Rock Research
New Jersey-based global medical device company Becton Dickinson & Co. (NYSE:BDX) said its CFO David Elkins will step down after the company reports financial results on Nov. 7 as he prepares to pursue an “entrepreneurial opportunity" at Round Rock Research, according to regulatory filings.
“This will give me an opportunity to work with a long-time friend at Round Rock as its CFO and help the company execute its growth strategy,” Elkins said in prepared remarks.
Elkins joined Becton Dickinson in December 2008, prior to which he was VP and CFO at AstraZeneca Pharmaceuticals.
"I am genuinely disappointed that we are losing David,” said BD president & CEO Vincent Forlenza in a prepared statement. “He has been an outstanding chief financial officer and terrific partner since he joined BD in 2008, but we respect his decision to pursue the next chapter of his career elsewhere. The board and I are grateful for his contributions to BD and for his commitment to helping achieve a smooth transition. We wish him the best for the future."
The company named Suketu Upadhyay, BD senior vice president and controller, as interim CFO while the healthcare giant searches for a replacement.
Sonoma Orthopedic Products named new CEO
Sonoma Orthopedic Products named Rick Epstein its president and CEO, also adding him to the board of directors.
CircuLite named new board of director
New Jersey-based medical device company CircuLite named Dr. Eric Rose as chairman of its board of directors.
Rose is currently executive VP of life sciences at MacAndrews & Forbes and has been a director at CircuLite since November 2011. Rose was previously a professor at Columbia University’s College of Physicians and Surgeons.